(Q47942964)

English

Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

0 references

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

author name string

Kathryn W Mason

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Duzhang Zhu

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Catherine A Scheuer

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

John C McMichael

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Gary W Zlotnick

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Bruce A Green

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

22

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

25-26

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

3449-3456

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Panel discussion: pathogenesis of otitis media. Bacteriology and immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

NADP and NAD utilization in Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Contribution of the DDDD motif of H. influenzae e (P4) to phosphomonoesterase activity and heme transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Are there any clinical indications for measuring IgG subclasses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.027

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15308371

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47942964&oldid=1637754092"